Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05763940 · ClinicalTrials.gov registry record · NA
Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
A NA study of Age-related Macular Degeneration and Dry Eye Syndromes, sponsored by Western University of Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT05763940 is a NA study of Age-related Macular Degeneration and Dry Eye Syndromes that is active but no longer recruiting, run by Western University of Health Sciences. The registered enrollment target is 130 participants, below the 1,506-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05763940, a NA study of Age-related Macular Degeneration and Dry Eye Syndromes, is active but no longer recruiting, sponsored by Western University of Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine increases in the Omega Index test indicating optimal Omega-3s particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels for overall systemic benefits including healthy cardiovascular health and cholesterol levels as shown in the OmegaIndex (OmegaQuant) research.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT OmegaBoost
- DIETARY_SUPPLEMENT Nature Made (soft gel)
- DIETARY_SUPPLEMENT Nature Made (gummy)
Study Locations (1)
California
- Western University of Health Sciences - Pomona
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2022-05-25 |
| Est. Completion | 2024-06-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05763940
The ClinicalTrials.gov registry entry for NCT05763940 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,506-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (91% lower). The listed sponsor is Western University of Health Sciences, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 3 interventions - of which OmegaBoost is the first listed.
NCT05763940 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05763940 about?
NCT05763940 is a clinical study titled "Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals". The purpose of this study is to determine increases in the Omega Index test indicating optimal Omega-3s particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels for overall systemic benefits including healthy cardiovascular health and cholesterol levels as shown in the OmegaInd...
What is the current status of trial NCT05763940?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2022-05-25. Estimated completion is 2024-06-25.
What conditions does trial NCT05763940 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration, Dry Eye Syndromes, Omega 3 Index.
What interventions are being tested in trial NCT05763940?
The interventions under investigation include: OmegaBoost (DIETARY_SUPPLEMENT), Nature Made (soft gel) (DIETARY_SUPPLEMENT), Nature Made (gummy) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05763940?
This trial is sponsored by Western University of Health Sciences, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05763940 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
-
Lutein, Zeaxathin, and Fish Oil Supplementation
RECRUITING · NA
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
-
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.